vimarsana.com
  1. Home
  2. Live Updates
  3. Jacob Johnson Stephens Inc - Breaking News

Jacob Johnson Stephens Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Avid Bioservices, Inc (CDMO) Q1 2023 Earnings Call Transcript

CDMO earnings call for the period ending June 30, 2022.

United statesJacob johnsonDan hartPaul knight keybancBristol myers squibbMatthew hewittTim bronsNick greenThomas kelliherPaul knightPrem patelMatt kwietniakExchange commissionMatt hewitt craig hallum capital group analystAvid bioservices incJacob johnson stephens inc

Catalent (CTLT) Q4 2022 Earnings Call Transcript

CTLT earnings call for the period ending June 30, 2022.

Bruxelles capitaleUnited statesNorth carolinaJack meehanMorgan stanleyMayne pharmaTom castellanoPaul knight keybancJohn sourbeerAlessandro maselliDave windley jefferiesKaren flynnLuke sergott barclaysPaul knightEvan stoverDave windley

West Pharmaceutical Services (WST) Q2 2022 Earnings Call Transcript

WST earnings call for the period ending June 30, 2022.

United statesJacob johnsonAmerica merrill lynchLarry solowJustin lin william blairPaul knight keybancBernard birkettEric greenStephen lockhartJustin linQuintin laiPaul knightWilliam blairDerik de bruin bankJacob johnson stephens incSutter health

Avid Bioservices, Inc (CDMO) Q4 2022 Earnings Call Transcript

CDMO earnings call for the period ending March 31, 2022.

United statesTim bronsMatthew hewittJacob johnsonNick greenDan hartMatt kwietniakExchange commissionMatthew hewitt craig hallum capital group analystAvid bioservices incJacob johnson stephens incAvid bioservicesPrivate securities litigation reform actChief executiveMyford south facilityMyford south

Catalent (CTLT) Q3 2022 Earnings Call Transcript

CTLT earnings call for the period ending March 31, 2022.

United kingdomUnited statesNew jerseyWaals gewestBruxelles capitaleJulia quinnMorgan stanleyJacob johnsonTom castellanoPaul surdezJohn chiminskiErytech pharmaLuke sergottAlessandro maselliLuke sergott barclaysTask force for financial disclosure

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.